K, S., DP, M., N, R., H, C. d. G., H, F., & RJ, A. (2023). Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management. The Journal of clinical endocrinology and metabolism, 108(9), 2154. https://doi.org/10.1210/clinem/dgad134
Chicago Style (17th ed.) CitationK, Sarafoglou, Merke DP, Reisch N, Claahsen-van der Grinten H, Falhammar H, and Auchus RJ. "Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management." The Journal of Clinical Endocrinology and Metabolism 108, no. 9 (2023): 2154. https://doi.org/10.1210/clinem/dgad134.
MLA (9th ed.) CitationK, Sarafoglou, et al. "Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management." The Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 9, 2023, p. 2154, https://doi.org/10.1210/clinem/dgad134.